CD34 is the most consistent marker for SFT; however, some studies denied this.[12] Genetic diagnosis identified the NAB2-STAT6 fusion gene.[13] In this case, the patient tested positive for CD34; however, hemangiopericytoma and SFT were separately considered at the time of diagnosis, and genetic testing was not performed. The gene discussed is NAB2; the disease is hemangiopericytoma.